Health
Nanobodies inhibit SARS-CoV-2 infection, including emergent variants – Phys.org
Australian researchers have identified neutralizing nanobodies that block the SARS-CoV-2 virus from entering cells in preclinical models.
Australian researchers have identified neutralizing nanobodies that block the SARS-CoV-2 virus from entering cells in preclinical models.
The discovery paves the way for further investigations into nanobody-based treatments for COVID-19.
Published in PNAS, the research is part of a consortium-led effort, bringing together the expertise of Australian academic leaders in infectious diseases and antibody therapeutics at WEHI, the Doherty Institute and the Kirby Institute.
Using alpaca ‘nanobodies’…
-
Noosa News14 hours agoExperts share tiny home warning as interest from young people soars
-
Noosa News20 hours agoKarenia cristata species source of toxins in SA’s algal bloom, scientists believe
-
Noosa News18 hours agoThe Calile Hotel Named on the World’s 50 Best Hotels List
-
General10 hours agoConvicted mushroom murderer Erin Patterson outlines her reasons to appeal